Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries

Kidney International

Volumn 91, Issue 1, 2017, Pages 70-85

  Bábíčková, Janka ^a,b,c   Klinkhammer, Barbara M ^a   Buhl, Eva M ^a   Djudjaj, Sonja ^a   Hoss, Mareike ^a   Heymann, Felix ^a   Tacke, Frank ^a   Floege, Jürgen ^a   Becker, Jan U ^d   Boor, Peter ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Comenius University ^*  (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

chronic kidney disease; endothelial cells; endothelial dysfunction; leakage; microvasculature; ultrastructure

Indexed keywords

CD31 ANTIGEN; VASCULOTROPIN RECEPTOR 2; COL4A3BP PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOPSY TECHNIQUE; CAPILLARY ENDOTHELIAL CELL; CAVEOLA; CELL COUNT; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DISEASE COURSE; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY ISCHEMIA; MEMBRANE PERMEABILITY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPERFUSION INJURY; URETER OBSTRUCTION; ANIMAL; BASEMENT MEMBRANE; BIOPSY; C57BL MOUSE; CAPILLARY; COMPLICATION; CYTOLOGY; DISEASE MODEL; ENDOTHELIUM CELL; FIBROSIS; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; KIDNEY TUBULE; KNOCKOUT MOUSE; MALE; MICROCIRCULATION; MULTIPHOTON MICROSCOPY; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; TIME FACTOR; ULTRASTRUCTURE; VASCULARIZATION;

ANIMALS; BASEMENT MEMBRANE; BIOPSY; CAPILLARIES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIAL CELLS; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROCIRCULATION; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; PROTEIN-SERINE-THREONINE KINASES; REPERFUSION INJURY; TIME FACTORS; URETERAL OBSTRUCTION;

EID: 84996565973     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.07.038     Document Type: Article

References (61)

1. 1 Yuan, H.T., Li, X.Z., Pitera, J.E., et al. Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha. Am J Pathol 163 (2003), 2289–2301.
2. 2 Kairaitis, L.K., Wang, Y.P., Gassmann, M., et al. HIF-1 alpha expression follows microvascular loss in advanced murine adriamycin nephrosis. Am J Physiol Renal Physiol 288 (2005), F198–F206.
3. 3 Ohashi, R., Shimizu, A., Masuda, Y., et al. Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol 13 (2002), 1795–1805.
4. 4 Basile, D.P., Donohoe, D., Roethe, K., et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281 (2001), F887–F899.
5. 5 Matsumoto, M., Tanaka, T., Yamamoto, T., et al. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 15 (2004), 1574–1581.
6. 6 Namikoshi, T., Satoh, M., Horike, H., et al. Implication of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy. Nephron Physiol 102 (2006), 9–16.
7. 7 Ohashi, R., Kitamura, H., Yamanaka, N., Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 11 (2000), 47–56.
8. 8 Tanaka, T., Miyata, T., Inagi, R., et al. Hypoxia in renal disease with proteinuria and/or glomerular hypertension. Am J Pathol 165 (2004), 1979–1992.
9. 9 Kang, D.H., Joly, A.H., Oh, S.W., et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12 (2001), 1434–1447.
10. 10 Kang, D.H., Hughes, J., Mazzali, M., et al. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12 (2001), 1448–1457.
11. 11 Kang, D.H., Kanellis, J., Hugo, C., et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13 (2002), 806–816.
12. 12 Ishii, Y., Sawada, T., Kubota, K., et al. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int 67 (2005), 321–332.
13. 13 Choi, Y.J., Chakraborty, S., Nguyen, V., et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol 31 (2000), 1491–1497.
14. 14 Eardley, K.S., Kubal, C., Zehnder, D., et al. The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. Kidney Int 74 (2008), 495–504.
15. 15 Dimke, H., Sparks, M.A., Thomson, B.R., et al. Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney. J Am Soc Nephrol 26 (2015), 1027–1038.
16. 16 Baelde, H.J., Eikmans, M., Lappin, D.W., et al. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int 71 (2007), 637–645.
17. 17 Donderski, R., Szczepanek, J., Domagalski, K., et al. Analysis of relative expression level of VEGF (vascular endothelial growth factor), HIF-1alpha (hypoxia inducible factor 1alpha) and CTGF (connective tissue growth factor) genes in chronic glomerulonephritis (CGN) patients. Kidney Blood Press Res 38 (2013), 83–91.
18. 18 Lin, S.L., Chang, F.C., Schrimpf, C., et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 178 (2011), 911–923.
19. 19 Schrimpf, C., Xin, C., Campanholle, G., et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 23 (2012), 868–883.
20. 20 Long, D.A., Norman, J.T., Fine, L.G., Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol 8 (2012), 244–250.
21. 21 Fine, L.G., Restoring the function of a diseased kidney via its microvasculature. Nephron Exp Nephrol, 126, 2014, 82.
22. 22 Bijkerk, R., van Solingen, C., de Boer, H.C., et al. Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity. J Am Soc Nephrol 25 (2014), 1710–1722.
23. 23 Ehling, J., Babickova, J., Gremse, F., et al. Quantitative micro-computed tomography imaging of vascular dysfunction in progressive kidney diseases. J Am Soc Nephrol 27 (2016), 520–532.
24. 24 Yamaguchi, I., Tchao, B.N., Burger, M.L., et al. Vascular endothelial cadherin modulates renal interstitial fibrosis. Nephron Exp Nephrol 120 (2012), e20–e31.
25. 25 Simard, B., Gabra, B.H., Sirois, P., Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice. Can J Physiol Pharmacol 80 (2002), 1203–1207.
26. 26 Satchell, S.C., Braet, F., Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol 296 (2009), F947–F956.
27. 27 Stan, R.V., Kubitza, M., Palade, G.E., PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. Proc Natl Acad Sci U S A 96 (1999), 13203–13207.
28. 28 Martin, Y., Avendaño, C., Piedras, M.J., et al. Evaluation of Evans Blue extravasation as a measure of peripheral inflammation. Protocol Exchange, 2010, 10.1038/protex.2010.209.
29. 29 Oka, T., Kalesnikoff, J., Starkl, P., et al. Evidence questioning cromolyn's effectiveness and selectivity as a ‘mast cell stabilizer’ in mice. Lab Invest 92 (2012), 1472–1482.
30. 30 Boor, P., Babickova, J., Steegh, F., et al. Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis. Am J Pathol 185 (2015), 2132–2142.
31. 31 Kaukinen, A., Lautenschlager, I., Helin, H., et al. Peritubular capillaries are rarefied in congenital nephrotic syndrome of the Finnish type. Kidney Int 75 (2009), 1099–1108.
32. 32 Steegh, F.M., Gelens, M.A., Nieman, F.H., et al. Early loss of peritubular capillaries after kidney transplantation. J Am Soc Nephrol 22 (2011), 1024–1029.
33. 33 Manotham, K., Tanaka, T., Matsumoto, M., et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 15 (2004), 1277–1288.
34. 34 Flores, J., DiBona, D.R., Beck, C.H., et al. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest 51 (1972), 118–126.
35. 35 Ivanyi, B., Kemeny, E., Rago, P., et al. Peritubular capillary basement membrane changes in chronic renal allograft rejection: comparison of light microscopic and ultrastructural observations. Virchows Arch 459 (2011), 321–330.
36. 36 Morozumi, K., Oikawa, T., Fukuda, M., et al. Electron-microscopic peritubular capillary lesion is a specific and useful diagnostic indicator for chronic rejection of renal allografts showing less specific morphologic lesions in the cyclosporine era. Transplant Proc 29 (1997), 89–92.
37. 37 Shimizu, A., Yamada, K., Sachs, D.H., et al. Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis. Kidney Int 61 (2002), 1867–1879.
38. 38 Gough, J., Yilmaz, A., Miskulin, D., et al. Peritubular capillary basement membrane reduplication in allografts and native kidney disease: a clinicopathologic study of 278 consecutive renal specimens. Transplantation 71 (2001), 1390–1393.
39. 39 Liapis, G., Singh, H.K., Derebail, V.K., et al. Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts: old concepts revisited. Transplantation 94 (2012), 620–629.
40. 40 Hvala, A., Ferluga, D., Rott, T., et al. Peritubular capillary changes in alport syndrome, diabetic glomerulopathy, Balkan endemic nephropathy and hemorrhagic fever with renal syndrome. Ultrastruct Pathol 29 (2005), 451–459.
41. 41 Sato, S., Kitamura, H., Adachi, A., et al. Reduplicated basal lamina of the peritubular capillaries in renal biopsy specimens. J Submicrosc Cytol Pathol 37 (2005), 305–311.
42. 42 Xavier, S., Vasko, R., Matsumoto, K., et al. Curtailing endothelial TGF-beta signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD. J Am Soc Nephrol 26 (2015), 817–829.
43. 43 Aird, W.C., Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100 (2007), 158–173.
44. 44 DeLeve, L.D., Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology 61 (2015), 1740–1746.
45. 45 Yamamoto, I., Horita, S., Takahashi, T., et al. Caveolin-1 expression is a distinct feature of chronic rejection-induced transplant capillaropathy. Am J Transplant 8 (2008), 2627–2635.
46. 46 Criado, P.R., Criado, R.F., Takakura, C.F., et al. Ultrastructure of vascular permeability in urticaria. Isr Med Assoc 15 (2013), 173–177.
47. 47 Kamba, T., Tam, B.Y., Hashizume, H., VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290 (2006), H560–H576.
48. 48 Strickland, L.A., Jubb, A.M., Hongo, J.A., et al. Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF). J Pathol 206 (2005), 466–475.
49. 49 Tanaka, T., Nangaku, M., Angiogenesis and hypoxia in the kidney. Nat Rev Nephrol 9 (2013), 211–222.
50. 50 Barber, J.O., Alberding, J.P., Restrepo, J.M., et al. Simulated two-dimensional red blood cell motion, deformation, and partitioning in microvessel bifurcations. Ann Biomed Eng 36 (2008), 1690–1698.
51. 51 Alarcon, T., Byrne, H.M., Maini, P.K., A design principle for vascular beds: the effects of complex blood rheology. Microvasc Res 69 (2005), 156–172.
52. 52 Craciun, F.L., Ajay, A.K., Hoffmann, D., et al. Pharmacological and genetic depletion of fibrinogen protects from kidney fibrosis. Am J Physiol Renal Physiol 307 (2014), F471–F484.
53. 53 Sorensen-Zender, I., Rong, S., Susnik, N., et al. Role of fibrinogen in acute ischemic kidney injury. Am J Physiol Renal Physiol 305 (2013), F777–F785.
54. 54 Sorensen, I., Susnik, N., Inhester, T., et al. Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney Int 80 (2011), 1035–1044.
55. 55 Patibandla, P.K., Tyagi, N., Dean, W.L., et al. Fibrinogen induces alterations of endothelial cell tight junction proteins. J Cell Physiol 221 (2009), 195–203.
56. 56 Eitner, F., Bucher, E., van Roeyen, C., et al. PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J Am Soc Nephrol 19 (2008), 281–289.
57. 57 Boor, P., Konieczny, A., Villa, L., et al. Complement C5 mediates experimental tubulointerstitial fibrosis. J Am Soc Nephrol 18 (2007), 1508–1515.
58. 58 Djudjaj, S., Papasotiriou, M., Bulow, R.D., et al. Keratins are novel markers of renal epithelial cell injury. Kidney Int 89 (2016), 792–808.
59. 59 Boor, P., van Roeyen, C.R., Kunter, U., et al. PDGF-C mediates glomerular capillary repair. Am J Pathol 177 (2010), 58–69.
60. 60 Ehling, J., Theek, B., Gremse, F., et al. Micro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization. Am J Pathol 184 (2014), 431–441.
61. 61 Heymann, F., Niemietz, P.M., Peusquens, J., et al. Long term intravital multiphoton microscopy imaging of immune cells in healthy and diseased liver using CXCR6.Gfp reporter mice. J Vis Exp(97), 2015 Mar 24.